calcimedica inc glp-1 receptor agonist weight management diabetes treatments Clinical of Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 Agonists - Shah - 2026 - Diabetes, Obesity and Metabolism Care and cost benefits of

If validated in adequately powered human trials, this would be a genuinely new mechanism for substance use disorders, rooted in metabolic signalling rather than monoamine modulation

Studies have found that (Val 8 )GLP-1 protects synapses from the detrimental effects of A fragments on synaptic plasticity formation (171173)

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Holman R.R., Bethel M.A., Mentz R.J., Thompson V.P., Lokhnygina Y., Buse J.B., Chan J.C., Choi J., Gustavson S.M., Iqbal N., et al

This analysis reveals a greater degree of engagement of tirzepatide for the GIP receptor than the GLP-1 receptor, corroborating an imbalanced mechanism of action